This role assists in the development, validation, implementation, and interpretation of advanced molecular and genomic assays used to identify clinically actionable alterations in oncology specimens, including circulating tumor DNA (ctDNA) and inherited genomic variants relevant to cancer predisposition and pharmacogenomics. The Technical Director works collaboratively with laboratory leadership, molecular geneticists, pathologists, laboratory operations, quality, bioinformatics, and oncology teams to ensure high-quality, compliant, and clinically meaningful molecular testing services.